Orange County NC Website
Browse       Search
Exhibit B <br />Start Date: 7/1/2024 <br />End Date: 6/30/2025 <br />Description Count How were efforts supported?Notes Additional Information & Helpful Hints about this Measure <br /># of naloxone kits distributed A naloxone kit contains two doses. <br /># of OTPs that dispense methadone, buprenorphine, and naltrexone <br /># of OTPs that dispense only methadone <br /># of OTP-based medical providers who prescribe methadone for OUD <br />patients <br />A provider may participate in multiple support programs so there may be <br />some duplication of # of providers. <br /># of referrals to opioid treatment programs Number of referrals do not equate to number of unique patients because <br />one individual may receive multiple referrals. <br /># of unique patients with OUD served at OTP <br />A unique patient may participate in multiple treatment programs so there <br />may be some duplication of unique patients when numbers across <br />programs, project, sites, etc., are aggregated for the strategy-specific <br />impact report. A patient may receive services across local government <br />boundaries (e.g., a person with OUD may reside in one county and receive <br />services in another county). <br /># of office-based clinics offering MOUD within county <br /># of individual OBOT providers who prescribe buprenorphine for <br />patients <br />A provider may participate in multiple support programs so there may be <br />some duplication of # of providers. <br /># of buprenorphine prescriptions provided at OBOT <br /># of naltrexone doses provided at OBOT <br /># of referrals to OBOT Number of referrals do not equate to number of unique patients because <br />one individual may receive multiple referrals. <br /># of unique patients with OUD served at OBOT <br />A unique patient may participate in multiple treatment programs so there <br />may be some duplication of unique patients when numbers across <br />programs, project, sites, etc., are aggregated for the strategy-specific <br />impact report. A patient may receive services across local government <br />boundaries (e.g., a person with OUD may reside in one county and receive <br />services in another county). <br /># of FQHCs offering MOUD within county <br /># of individual FQHC providers who prescribe buprenorphine for <br />patients <br />A provider may participate in multiple support programs so there may be <br />some duplication of # of providers. <br /># of buprenorphine prescriptions provided at FQHC <br /># of naltrexone doses provided at FQHC <br /># of referrals to FQHC MAT services Number of referrals do not equate to number of unique patients because <br />one individual may receive multiple referrals. <br /># of unique patients with OUD served at FQHC <br />A unique patient may participate in multiple treatment programs so there <br />may be some duplication of unique patients when numbers across <br />programs, project, sites, etc., are aggregated for the strategy-specific <br />impact report. A patient may receive services across local government <br />boundaries (e.g., a person with OUD may reside in one county and receive <br />services in another county). <br /># of hospitals offering in-patient MOUD within county <br /># of hospitalists who prescribe buprenorphine for patients A provider may participate in multiple support programs so there may be <br />some duplication of # of providers. <br /># of buprenorphine prescriptions provided through in-patient services <br />in hospitals <br /># of naltrexone doses provided through in-patient services in hospitals <br />2. Evidence-Based Treatment <br />Insert Start and End Date for this Strategy (MM/DD/YYYY) <br />Process measures answer the question, “How much did you do?”. Please quantify the process measures relevant to your implementation of this strategy. Indicate whether the <br />count represents efforts supported only by opioid settlement funds or efforts supported by multiple funding sources including opioid settlement funds. Process measures <br />should reflect numbers from the 2024 fiscal year (i.e., July 1, 2024-June 30, 2025). <br />STRATEGY-SPECIFIC PROCESS MEASURES <br />Docusign Envelope ID: C2CD9F79-7C8E-4B6B-8B12-D37C626968D7